Cargando…
Prediction of recurrence-free survival using a protein expression-based risk classifier for head and neck cancer
Loco-regional recurrence in 50% of oral squamous cell carcinoma (OSCC) patients poses major challenge for oncologists. Lack of biomarkers that can predict disease aggressiveness and recurrence risk makes the scenario more dismal. On the basis of our earlier global proteomic analyses we identified fi...
Autores principales: | Chauhan, S S, Kaur, J, Kumar, M, Matta, A, Srivastava, G, Alyass, A, Assi, J, Leong, I, MacMillan, C, Witterick, I, Colgan, T J, Shukla, N K, Thakar, A, Sharma, M C, Siu, K W M, Walfish, P G, Ralhan, R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491610/ https://www.ncbi.nlm.nih.gov/pubmed/25893634 http://dx.doi.org/10.1038/oncsis.2015.7 |
Ejemplares similares
-
Prognostic significance of cytoplasmic S100A2 overexpression in oral cancer patients
por: Kumar, Manish, et al.
Publicado: (2015) -
Nuclear Ep-ICD Expression Is a Predictor of Poor Prognosis in “Low Risk” Prostate Adenocarcinomas
por: Assi, Jasmeet, et al.
Publicado: (2015) -
Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis
por: Somasundaram, Raj Thani, et al.
Publicado: (2016) -
ER maleate is a novel anticancer agent in oral cancer: implications for cancer therapy
por: Fu, Guodong, et al.
Publicado: (2016) -
Biotinidase is a Novel Marker for Papillary Thyroid Cancer Aggressiveness
por: So, Anthony K.-C., et al.
Publicado: (2012)